Literature DB >> 25999300

Diurnal Salivary Cortisol and Regression Status in MECP2 Duplication Syndrome.

Sarika U Peters1, Breanne J Byiers2, Frank J Symons2.   

Abstract

MECP2 duplication syndrome is an X-linked genomic disorder that is characterized by infantile hypotonia, intellectual disability, and recurrent respiratory infections. Regression affects a subset of individuals, and the etiology of regression has yet to be examined. In this study, alterations in the hypothalamus-pituitary-adrenal axis, including diurnal patterns in salivary cortisol, were examined in 4 males with MECP2 duplication syndrome who had regression and 4 males with the same syndrome without regression (aged 3-22 years). Individuals who had experienced regression do not exhibit typical diurnal cortisol rhythms, and their profiles were flatter through the day. In contrast, individuals with MECP2 duplication syndrome who had not experienced regression showed more typical patterns of higher cortisol levels in the morning with linear decreases throughout the day. This study is the first to suggest a link between atypical diurnal cortisol rhythms and regression status in MECP2 duplication syndrome and may have implications for treatment.
© The Author(s) 2015.

Entities:  

Keywords:  MECP2; cortisol; regression

Mesh:

Substances:

Year:  2015        PMID: 25999300      PMCID: PMC4654987          DOI: 10.1177/0883073815585577

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  22 in total

1.  MECP2 Duplication Syndrome.

Authors:  H Van Esch
Journal:  Mol Syndromol       Date:  2011-07-05

2.  Early regression in social communication in autism spectrum disorders: a CPEA Study.

Authors:  Rhiannon Luyster; Jennifer Richler; Susan Risi; Wan-Ling Hsu; Geraldine Dawson; Raphael Bernier; Michelle Dunn; Susan Hepburn; Susan L Hyman; William M McMahon; Julie Goudie-Nice; Nancy Minshew; Sally Rogers; Marian Sigman; M Anne Spence; Wendy A Goldberg; Helen Tager-Flusberg; Fred R Volkmar; Catherine Lord
Journal:  Dev Neuropsychol       Date:  2005       Impact factor: 2.253

3.  Cortisol during the day in patients with systemic lupus erythematosus or primary Sjogren's syndrome.

Authors:  Marlies C van der Goes; Ercolie R Bossema; André Hartkamp; Guido L R Godaert; Johannes W G Jacobs; Aike A Kruize; Ronald H W M Derksen; Johannes W J Bijlsma; Rinie Geenen
Journal:  J Rheumatol       Date:  2010-12-15       Impact factor: 4.666

4.  Recurrent infections, hypotonia, and mental retardation caused by duplication of MECP2 and adjacent region in Xq28.

Authors:  Michael J Friez; Julie R Jones; Katie Clarkson; Herbert Lubs; Dianne Abuelo; Jo-Ann Blaymore Bier; Shashidhar Pai; Richard Simensen; Charles Williams; Philip F Giampietro; Charles E Schwartz; Roger E Stevenson
Journal:  Pediatrics       Date:  2006-11-06       Impact factor: 7.124

5.  Associations of salivary cortisol levels with inflammatory markers: the Multi-Ethnic Study of Atherosclerosis.

Authors:  A S DeSantis; A V DiezRoux; A Hajat; A E Aiello; S H Golden; N S Jenny; T E Seeman; S Shea
Journal:  Psychoneuroendocrinology       Date:  2011-12-16       Impact factor: 4.905

6.  Early developmental regression in autism spectrum disorder: evidence from an international multiplex sample.

Authors:  Jeremy R Parr; Ann Le Couteur; Gillian Baird; Michael Rutter; Andrew Pickles; Eric Fombonne; Anthony J Bailey
Journal:  J Autism Dev Disord       Date:  2011-03

7.  Serum cortisol reduction and abnormal prolactin and CD4+/CD8+ T-cell response as a result of controlled exercise in patients with rheumatoid arthritis and systemic lupus erythematosus despite unaltered muscle energetics.

Authors:  A J Pool; B J Whipp; A J Skasick; A Alavi; J M Bland; J S Axford
Journal:  Rheumatology (Oxford)       Date:  2003-07-16       Impact factor: 7.580

8.  HPA axis activity in multiple sclerosis correlates with disease severity, lesion type and gene expression in normal-appearing white matter.

Authors:  Jeroen Melief; Stella J de Wit; Corbert G van Eden; Charlotte Teunissen; Jörg Hamann; Bernard M Uitdehaag; Dick Swaab; Inge Huitinga
Journal:  Acta Neuropathol       Date:  2013-06-28       Impact factor: 17.088

9.  Deletion of Mecp2 in Sim1-expressing neurons reveals a critical role for MeCP2 in feeding behavior, aggression, and the response to stress.

Authors:  Sharyl L Fyffe; Jeff L Neul; Rodney C Samaco; Hsiao-Tuan Chao; Shay Ben-Shachar; Paolo Moretti; Bryan E McGill; Evan H Goulding; Elinor Sullivan; Laurence H Tecott; Huda Y Zoghbi
Journal:  Neuron       Date:  2008-09-25       Impact factor: 17.173

10.  Common variants within MECP2 confer risk of systemic lupus erythematosus.

Authors:  Amr H Sawalha; Ryan Webb; Shizhong Han; Jennifer A Kelly; Kenneth M Kaufman; Robert P Kimberly; Marta E Alarcón-Riquelme; Judith A James; Timothy J Vyse; Gary S Gilkeson; Chan-Bum Choi; R Hal Scofield; Sang-Cheol Bae; Swapan K Nath; John B Harley
Journal:  PLoS One       Date:  2008-03-05       Impact factor: 3.240

View more
  2 in total

1.  MeCP2 haplodeficiency and early-life stress interaction on anxiety-like behavior in adolescent female mice.

Authors:  María Abellán-Álvaro; Oliver Stork; Carmen Agustín-Pavón; Mónica Santos
Journal:  J Neurodev Disord       Date:  2021-12-11       Impact factor: 4.025

2.  Cortisol profiles and clinical severity in MECP2 duplication syndrome.

Authors:  Sarika U Peters; Cary Fu; Jeffrey L Neul; Douglas A Granger
Journal:  J Neurodev Disord       Date:  2020-07-22       Impact factor: 4.025

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.